Mutations of the tumor suppressor gene SOCS-1 in classical Hodgkin lymphoma are frequent and associated with nuclear phospho-STAT5 accumulation

Oncogene
M A WenigerP Möller

Abstract

The suppressors of cytokine signaling (SOCS) are critically involved in the regulation of cellular proliferation, survival, and apoptosis via cytokine-induced JAK/STAT signaling. SOCS-1 silencing by aberrant DNA methylation contributes to oncogenesis in various B-cell neoplasias and carcinomas. Recently, we showed an alternative loss of SOCS-1 function due to deleterious SOCS-1 mutations in a major subset of primary mediastinal B-cell lymphoma (PMBL) and in the PMBL line MedB-1, and a biallelic SOCS-1 deletion in PMBL line Karpas1106P. For both cell lines our previous data demonstrated retarded JAK2 degradation and sustained phospho-JAK2 action leading to enhanced DNA binding of phospho-STAT5. Here, we analysed SOCS-1 in laser-microdissected Hodgkin and Reed-Sternberg (HRS) cells of classical Hodgkin lymphoma (cHL). We detected SOCS-1 mutations in HRS cells of eight of 19 cHL samples and in three of five Hodgkin lymphoma (HL)-derived cell lines by sequencing analysis. Moreover, we found a significant association between mutated SOCS-1 of isolated HRS cells and nuclear phospho-STAT5 accumulation in HRS cells of cHL tumor tissue (P < 0.01). Collectively, these findings support the concept that PMBL and cHL share many overlapping ...Continue Reading

References

Feb 21, 1998·Proceedings of the National Academy of Sciences of the United States of America·D J HiltonN A Nicola
Apr 25, 2001·Cell Death and Differentiation·J SträterP Möller
Sep 13, 2001·Stem Cells·D L Krebs, D J Hilton
Jun 18, 2002·The Lancet Oncology·Thomas F E BarthPeter Möller
Jun 25, 2002·Oncogene·Robert RottapelPaulo de Sepulveda
Dec 13, 2002·International Journal of Cancer. Journal International Du Cancer·Stefan JoosAnna Jauch
May 22, 2003·Genes, Chromosomes & Cancer·Chien-Yuan ChenHwei-Fang Tien
Mar 27, 2004·Blood·Chrystelle GuiterFlavia Castellano
Apr 28, 2004·Leukemia Research·C S ChimR Liang
Sep 14, 2004·Oncogene·Kate D SutherlandJane E Visvader
Apr 29, 2005·The New England Journal of Medicine·Robert KralovicsRadek C Skoda
Jul 13, 2005·European Journal of Haematology. Supplementum·Sibrand PoppemaPeter Möller
Nov 16, 2005·International Journal of Cancer. Journal International Du Cancer·Ingo MelznerPeter Möller

❮ Previous
Next ❯

Citations

Dec 30, 2006·Der Pathologe·T F E Barth, P Möller
Dec 17, 2009·Der Pathologe·S Hartmann, M L Hansmann
Jan 16, 2013·Der Pathologe·S Hartmann, M L Hansmann
Jul 27, 2011·Current Oncology Reports·Pier Luigi Zinzani, Pier Paolo Piccaluga
Jan 13, 2009·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Cecile MeierAlexandar Tzankov
Apr 6, 2013·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Young Wha KohJooryung Huh
Aug 28, 2007·Nature Reviews. Cancer·Ross L LevineD Gary Gilliland
Dec 17, 2008·Nature Reviews. Cancer·Ralf Küppers
Dec 15, 2010·Nature Reviews. Clinical Oncology·Anas Younes
May 26, 2007·Nature Reviews. Immunology·Akihiko YoshimuraMasato Kubo
Aug 8, 2012·Oncogene·W Vainchenker, S N Constantinescu
Apr 16, 2010·The New England Journal of Medicine·Georg Lenz, Louis M Staudt
May 24, 2006·The Journal of Experimental Medicine·Toshikatsu HanadaAkihiko Yoshimura
Apr 27, 2011·The Journal of Experimental Medicine·Kenneth J OestreichAmy S Weinmann
Sep 1, 2006·Photomedicine and Laser Surgery
Sep 8, 2009·Nucleic Acids Research·Lu Ping TanAnke van den Berg
Apr 30, 2009·Annual Review of Pathology·Roland SchmitzRalf Küppers
Jan 25, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Michael R GreenMargaret A Shipp
Oct 2, 2012·The Journal of Clinical Investigation·Ralf KüppersMartin-Leo Hansmann
Dec 17, 2008·Hematology·Peter W M Johnson, Andrew J Davies
Apr 30, 2009·Blood·Aldo M RoccaroIrene M Ghobrial
Jun 22, 2006·International Journal of Hematology·Marc A WenigerPeter Möller
Aug 10, 2012·Haematologica·Andrew ChaseNicholas C P Cross
Jan 19, 2008·World Journal of Gastroenterology : WJG·Zhi-Xin ZhaoZhi-Liang Gao
Jan 20, 2011·Cancer Informatics·Xuesong HanShuangge Ma
Apr 24, 2014·Molecular Biology International·Walid SasiKefah Mokbel
Aug 23, 2006·Future Oncology·Victor YazbeckAnas Younes
Oct 11, 2013·Future Oncology·Adriana AritaJoshua D Brody
Apr 8, 2014·Cellular and Molecular Life Sciences : CMLS·Julhash U KaziLars Rönnstrand
Apr 27, 2012·Advances in Hematology·Kenneth A FoonPier L Zinzani

❮ Previous
Next ❯

Related Concepts

Related Feeds

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.